Trending...
- What Colorado Leaders, Communities, and Residents Are Saying About Federal Approval for Public Assistance for Major Disasters
- 303 Crown Maids Enhances Commercial Cleaning Services Page for Local Businesses
- Supporting Colorado's Cultural Legacy: 25 New Folk and Traditional Arts Initiatives Awarded Across the State
DENVER, Sept. 10, 2021 /PRNewswire/ -- For the first time, the IASLC's Staging and Prognostic Factors Committee (SPFC) has accumulated molecular biomarker data to complement Tumor, Node, and Metastasis (TNM)-based prognostication. Results from the committee's first effort were reported today at the IASLC 2021 World Conference on Lung Cancer in OA06: Prognosis and Staging.
Biomarker-directed treatment and prognostication are changing lung cancer care. Differences in the prevalence, and disparities in use, of biomarkers inhibit dissemination of personalized cancer care on a global scale, reported Professor Raymond Osarogiagbon, Baptist Cancer Center, Memphis, Tenn. In the TNM system: the "T" refers to the size and extent of the main tumor; the "N" refers to whether and where lymph nodes are involved with cancer; and the "M" refers to whether the cancer has metastasized to other sites.
To create the data set, the IASLC Staging and Prognostic Factor Committee collected 64,434 lung cancer cases diagnosed from 2010 to 2019, staged by 8th Edition of the TNM Classification for Thoracic Cancers , from Asia, Australia, North America and Europe.
More on Colorado Desk
The committee reported on data sources, NSCLC characteristics and biomarker data (ALK, BRAF, EGFR, KRAS, ROS1, MET, RET, NTRK1, ERBB2 or PD-L1) submitted by Electronic Data Capture (EDC) and compared EDC cases with and without biomarker data as of April 1, 2021.
Of the 64,434 cases in the committee's NSCLC database, 6,611 (10%) were EDC cases; of these, 2,068 (31%) had biomarker data. All biomarker data came from 14 countries including China (28%), Canada (25%), Spain (15%), Australia (10%), and India (5%). Cases with biomarker data were more likely to be adenocarcinoma, of advanced stage, and nonsurgical, although 46% of patients had undergone surgery.
Single gene tests predominated, with EGFR (70%) being most common. Most cases were wildtype, ranging from 68% of KRAS- to 100% of NTRK-tested cases.
"This database will expand as we include non-EDC cases. However, given the potential for a global database to create insights into patterns and outcomes of lung cancer care, a more comprehensive recruitment of additional institutions, countries, and continents is needed to ensure that the dataset reflects the global epidemiology of lung cancer," said Prof. Osarogiagbon.
About the IASLC:
More on Colorado Desk
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes nearly 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the WCLC:
The WCLC is the world's largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2021.iaslc.org/.
Contact: Chris Martin, IASLC Media Relations, [email protected]
SOURCE International Association for the Study of Lung Cancer
Biomarker-directed treatment and prognostication are changing lung cancer care. Differences in the prevalence, and disparities in use, of biomarkers inhibit dissemination of personalized cancer care on a global scale, reported Professor Raymond Osarogiagbon, Baptist Cancer Center, Memphis, Tenn. In the TNM system: the "T" refers to the size and extent of the main tumor; the "N" refers to whether and where lymph nodes are involved with cancer; and the "M" refers to whether the cancer has metastasized to other sites.
To create the data set, the IASLC Staging and Prognostic Factor Committee collected 64,434 lung cancer cases diagnosed from 2010 to 2019, staged by 8th Edition of the TNM Classification for Thoracic Cancers , from Asia, Australia, North America and Europe.
More on Colorado Desk
- Michael H. Kaplan Recognized for 17 Years on PHPA Workers' Compensation Panel and Advocacy for Professional Athletes
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Boston Industrial Solutions Introduces Personalized Printing Training
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
The committee reported on data sources, NSCLC characteristics and biomarker data (ALK, BRAF, EGFR, KRAS, ROS1, MET, RET, NTRK1, ERBB2 or PD-L1) submitted by Electronic Data Capture (EDC) and compared EDC cases with and without biomarker data as of April 1, 2021.
Of the 64,434 cases in the committee's NSCLC database, 6,611 (10%) were EDC cases; of these, 2,068 (31%) had biomarker data. All biomarker data came from 14 countries including China (28%), Canada (25%), Spain (15%), Australia (10%), and India (5%). Cases with biomarker data were more likely to be adenocarcinoma, of advanced stage, and nonsurgical, although 46% of patients had undergone surgery.
Single gene tests predominated, with EGFR (70%) being most common. Most cases were wildtype, ranging from 68% of KRAS- to 100% of NTRK-tested cases.
"This database will expand as we include non-EDC cases. However, given the potential for a global database to create insights into patterns and outcomes of lung cancer care, a more comprehensive recruitment of additional institutions, countries, and continents is needed to ensure that the dataset reflects the global epidemiology of lung cancer," said Prof. Osarogiagbon.
About the IASLC:
More on Colorado Desk
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Notaron Expands Online Notarization Access Following Wisconsin Approval
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- Colorado: Governor Polis Celebrates the U.S. Supreme Court Blocking the Trump Administration's Efforts to Make it Harder for Americans and Coloradans to Vote
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes nearly 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the WCLC:
The WCLC is the world's largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2021.iaslc.org/.
Contact: Chris Martin, IASLC Media Relations, [email protected]
SOURCE International Association for the Study of Lung Cancer
Filed Under: Business
0 Comments
Latest on Colorado Desk
- Colorado Springs: Hancock Expressway segment closes Sept. 18-Oct. 3 for construction
- Colorado Springs Airport nominated for USA TODAY 10BEST Readers' Choice Award
- Kristen Hoffecker sworn in as Presiding Judge of Colorado Springs Municipal Court
- Lt. Governor Dianne Primavera Commemorates 9/11 National Day of Service with Visit to Farmer in Training Program in Southwest Colorado
- Colorado Springs: CSPD is seeking potential additional victims in sexual Assault of a Child Investigation
- Colorado Springs: September brings Manitou Incline closures and new Pikes Peak operating hours
- Colorado Springs: Deceased persons identified from two-vehicle crash on Marksheffel Road south of East Gate Street
- Colorado: Governor Polis Appoints V. William Scarpato, III to the 2nd Judicial District Court
- Colorado: Governor Polis Memorializes Verbal Disaster Declaration for The Post, Sheep Pen, High Fence, and Gotera Fires in Las Animas County
- Lt. Governor Primavera Highlights Colorado's Innovative Aerospace Industry in Durango
- Colorado: Governor Polis Appoints David K. Ottman to the 6th Judicial District Court
- The Chartered Institute of Linguists Cites AI SEO Expert Chris Raulf on the Expertise Beneath the Task
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- Colorado: Governor Polis Orders Flags to Half-Staff Honoring the 25th Anniversary of September 11th
- Governor Polis Celebrates Strong International Partnership at Japan America Society of Colorado Annual Gala
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight